SCHEMBL69975

SCHEMBL69975

BrCC(I)CI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL67565 0.74
SCHEMBL8399566 0.72
SCHEMBL3684000 0.67
SCHEMBL18106963 0.67
SCHEMBL10902059 0.67
SCHEMBL1040262 0.65
SCHEMBL5474400 0.65
SCHEMBL1040304 0.65
SCHEMBL9816466 0.61
SCHEMBL16404090 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024141535-A1 NLRP3 INFLAMMASOME INHIBITORS ASTRAZENECA AB (SE) 2024-07-04 WO disclosed
US-11771651-B2 Liposomes and uses thereof ACADEMIA SINICA (TW) 2023-10-03 US disclosed
US-20220151926-A1 LIPOSOMES AND USES THEREOF ACADEMIA SINICA (TW) 2022-05-19 US disclosed
CN-110655585-A Synthetic polypeptides and uses thereof 中央研究院 2020-01-07 CN disclosed
US-8129552-B2 for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2012-03-06 US disclosed
WO-2010093601-A1 NOVEL SULFONIC ACID-CONTAINING THYROMIMETICS, AND METHODS FOR THEIR USE METABASIS THERAPEUTICS, INC. (US) 2010-08-19 WO disclosed
US-20080214849-A1 PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSHAFTEN E.V. (DE) 2008-09-04 US disclosed
US-20050100968-A1 Self-encoded combinatorial synthesis of compound multiplets XENOPORT, INC. (US) 2005-05-12 US disclosed
WO-2005014525-A2 BI-ARYL COMPOUND HAVING IMMUNOSUPPRESSIVE ACTIVITY MITSUBISHI PHARMA CORPORATION (JP) 2005-02-17 WO disclosed
EP-1259823-A2 SELF-ENCODED COMBINATORIAL SYNTHESIS OF COMPOUND MULTIPLETS Xenoport, Inc. (US) 2002-11-27 EP disclosed
US-20010031475-A1 Self-encoded combinatorial synthesis of compound multiplets XENOPORT, INC. 2001-10-18 US disclosed
WO-2001062772-A2 SELF-ENCODED COMBINATORIAL SYNTHESIS OF COMPOUND MULTIPLETS XENOPORT, INC. (US) 2001-08-30 WO disclosed